Cargando…
Predicting T cell recognition of MHC class I restricted neoepitopes
Epitopes that arise from a somatic mutation, also called neoepitopes, are now known to play a key role in cancer immunology and immunotherapy. Recent advances in high-throughput sequencing have made it possible to identify all mutations and thereby all potential neoepitope candidates in an individua...
Autores principales: | Koşaloğlu-Yalçın, Zeynep, Lanka, Manasa, Frentzen, Angela, Logandha Ramamoorthy Premlal, Ashmitaa, Sidney, John, Vaughan, Kerrie, Greenbaum, Jason, Robbins, Paul, Gartner, Jared, Sette, Alessandro, Peters, Bjoern |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204999/ https://www.ncbi.nlm.nih.gov/pubmed/30377561 http://dx.doi.org/10.1080/2162402X.2018.1492508 |
Ejemplares similares
-
Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4(+) T cells
por: Brightman, Spencer E., et al.
Publicado: (2023) -
Estimating tissue-specific peptide abundance from public RNA-Seq data
por: Frentzen, Angela, et al.
Publicado: (2023) -
Linked CD4(+)/CD8(+) T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
por: Dolina, Joseph S., et al.
Publicado: (2023) -
Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2022) -
Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA‐DQ2.5
por: Koşaloğlu‐Yalçın, Zeynep, et al.
Publicado: (2020)